<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) December 18, 1997 (December
15, 1997)
Commission File No. 0-11772
NU-TECH BIO-MED, INC.
-------------------------
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C>
Delaware 25-1411971
-------------- ----------------
(State or other jurisdiction of IRS Employer Identification No.
incorporation of organization)
476 Main Street, Suite 3-DFL, Wakefield, Rhode Island 02879
- ----------------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
</TABLE>
Registrant's telephone number, including area code: (401) 789-9995
55 Access Road, Suite 700, Warwick, Rhode Island 02886
------------------------------------------------------
(Former name or former address, if changed since last report.)
Page 1 of 3
<PAGE> 2
ITEM 5. OTHER EVENTS
Effective December 15, 1997, the Registrant is relocating its principal
executive offices. The Registrant's principal executive offices will now be
located at 476 Main Street, Suite 3-DFL, Wakefield, Rhode Island 02879. The
Registrant's new telephone number, effective December 15, 1997, is (401)
789-9995 and fax number is (401) 789-9934.
Page 2 of 3
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report on form 8-K to be signed on its
behalf by the undersigned hereunto duly authorized.
NU-TECH BIO-MED, INC.
By: /s/ J. Marvin Feigenbaum
---------------------------
J. Marvin Feigenbaum
Chairman of the Board
President, Chief Executive
and Chief Financial Officer
Dated: December 18, 1997
Page 3 of 3